See more : Martin Marietta Materials, Inc. (MLM) Income Statement Analysis – Financial Results
Complete financial analysis of Aesthetic Medical International Holdings Group Limited (AIH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aesthetic Medical International Holdings Group Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Angel Fibers Limited (ANGEL.BO) Income Statement Analysis – Financial Results
- Kontoor Brands, Inc. (KTB) Income Statement Analysis – Financial Results
- Ayen Enerji A.S. (AYEN.IS) Income Statement Analysis – Financial Results
- Inventec Corporation (2356.TW) Income Statement Analysis – Financial Results
- Arrow Minerals Limited (AMD.AX) Income Statement Analysis – Financial Results
Aesthetic Medical International Holdings Group Limited (AIH)
About Aesthetic Medical International Holdings Group Limited
Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. It offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments comprising minimally invasive and energy-based treatments, including laser, ultrasound, and ultraviolet light treatments. The company also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. It operates 15 treatment centers in China, Hong Kong, and Singapore. Aesthetic Medical International Holdings Group Limited was founded in 1997 and is headquartered in Shenzhen, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 682.59M | 670.09M | 645.59M | 901.57M | 869.05M | 761.31M | 697.40M | 584.86M |
| Cost of Revenue | 360.54M | 314.51M | 376.09M | 356.80M | 275.95M | 258.57M | 234.52M | 217.34M |
| Gross Profit | 322.05M | 355.59M | 269.50M | 544.78M | 593.10M | 502.74M | 462.87M | 367.52M |
| Gross Profit Ratio | 47.18% | 53.07% | 41.74% | 60.43% | 68.25% | 66.04% | 66.37% | 62.84% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 138.61M | 150.38M | 206.97M | 230.65M | 196.33M | 115.49M | 92.84M | 121.76M |
| Selling & Marketing | 232.25M | 226.47M | 404.68M | 510.61M | 413.07M | 333.53M | 300.36M | 231.23M |
| SG&A | 370.86M | 376.85M | 611.65M | 741.25M | 609.40M | 449.01M | 393.20M | 352.99M |
| Other Expenses | 8.30M | -51.43M | 1.83M | -999.00K | 195.41M | -280.21M | -115.72M | 50.73M |
| Operating Expenses | 370.86M | 376.85M | 611.65M | 741.25M | 609.40M | 449.01M | 393.20M | 352.99M |
| Cost & Expenses | 731.40M | 691.36M | 987.75M | 1.10B | 885.35M | 707.58M | 627.72M | 570.33M |
| Interest Income | 78.00K | 155.00K | 113.00K | 1.19M | 388.00K | 322.00K | 868.00K | 309.00K |
| Interest Expense | 14.47M | 21.64M | 27.23M | 29.19M | 23.91M | 9.24M | 6.58M | 2.92M |
| Depreciation & Amortization | 65.90M | 61.49M | 99.14M | 106.41M | 83.83M | 32.14M | 29.11M | 38.73M |
| EBITDA | 25.47M | 9.67M | -240.99M | -90.93M | 177.37M | -192.29M | -17.48M | 91.91M |
| EBITDA Ratio | 3.73% | -1.65% | -37.33% | -21.89% | 20.41% | -25.26% | -2.51% | 18.11% |
| Operating Income | -48.81M | -72.54M | -340.13M | -303.74M | 93.54M | -227.49M | -50.83M | 66.98M |
| Operating Income Ratio | -7.15% | -10.83% | -52.68% | -33.69% | 10.76% | -29.88% | -7.29% | 11.45% |
| Total Other Income/Expenses | -6.25M | -72.91M | -339.16M | -63.02M | 168.66M | -287.70M | -122.85M | 10.51M |
| Income Before Tax | -55.06M | -94.17M | -681.31M | -259.49M | 152.36M | -233.97M | -53.17M | 64.24M |
| Income Before Tax Ratio | -8.07% | -14.05% | -105.53% | -28.78% | 17.53% | -30.73% | -7.62% | 10.98% |
| Income Tax Expense | -15.14M | -18.07M | -11.80M | -12.59M | 14.04M | 18.51M | 19.26M | 13.71M |
| Net Income | -37.43M | -76.11M | -669.52M | -246.91M | 136.31M | -255.24M | -76.68M | 50.35M |
| Net Income Ratio | -5.48% | -11.36% | -103.71% | -27.39% | 15.68% | -33.53% | -10.99% | 8.61% |
| EPS | -0.85 | -2.79 | -30.45 | -11.36 | 5.77 | -4.45 | -1.34 | 0.89 |
| EPS Diluted | -0.85 | -2.79 | -30.45 | -11.36 | 5.77 | -4.45 | -1.34 | 0.89 |
| Weighted Avg Shares Out | 43.89M | 27.30M | 21.99M | 21.74M | 23.61M | 57.40M | 57.40M | 56.66M |
| Weighted Avg Shares Out (Dil) | 43.89M | 27.30M | 21.99M | 21.74M | 23.61M | 57.40M | 57.40M | 56.66M |
Aesthetic Medical International Announces Restructuring Plans to Optimize Business Operations
SHENZHEN, China, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced a preliminary plan for business strategies and restructuring. In...
Aesthetic Medical International Holdings Group Limited (AIH) CEO Pengwu Zhou on Q1 2021 Results - Earnings Call Transcript
Aesthetic Medical International Holdings Group Limited (AIH) CEO Pengwu Zhou on Q1 2021 Results - Earnings Call Transcript
Aesthetic Medical International Holdings Group Limited Reports First Quarter 2021 Unaudited Financial Results
SHENZHEN, China, June 24, 2021 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announced its unaudited financial results for the first quarter ended March...
Aesthetic Medical International to Announce First Quarter 2021 Unaudited Financial Results on June 24, 2021
SHENZHEN, China, June 16, 2021 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it will release its unaudited first quarter 2021...
Aesthetic Medical International (AIH) Stock: Over 6% Increase Pre-Market Explanation
The stock price of Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH) increased by over 6% pre-market. This is why it happened.
Aesthetic Medical International Holdings Group Limited Announces USD$15.1 Million Private Placement with Lafang China Co., Ltd
SHENZHEN, China, May 17, 2021 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announced that it has entered into a definitive share subscription agreement...
Aesthetic Medical International Holdings Group Limited Filed Annual Report on Form 20-F for 2020
Shenzhen, China, April 30, 2021 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announced that it had filed its annual report on Form 20-F...
Aesthetic Medical International's (AIH) CEO Pengwu Zhou on Q4 2020 Results - Earnings Call Transcript
Aesthetic Medical International's (AIH) CEO Pengwu Zhou on Q4 2020 Results - Earnings Call Transcript
Aesthetic Medical International Holdings Group Limited Reports Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results
Shenzhen, China, April 20, 2021 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announces its unaudited financial results for the fourth quarter and fiscal...
Aesthetic Medical International Holdings Group Limited Announces Changes in its Committee Composition
Shenzhen, China, March 30, 2021 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that Mr. Tsang Eric Chi Wai has resigned from...
Source: https://incomestatements.info
Category: Stock Reports